Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS - Part II - Preanalytical issues

Cytometry Part B - Clinical Cytometry

Volumn 84, Issue 5, 2013, Pages 286-290

  Davis, Bruce H ^a   Dasgupta, Amar ^b   Kussick, Steven ^c   Han, Jin Yeong ^d   Estrellado, Annalee ^e  

^a Trillium Diagnostics   (United States)

^b SRL Diagnostics   (India)

^c PATH   (United States)

^d Dong A University   (South Korea)

^e BIOGEN   (United States)

Author keywords

Flow Cytometry; laboratory hematology; practice guideline; regulatory science; standardization

Indexed keywords

LUTEINIZING HORMONE;

CELL ASSAY; CELL COUNT; CELL STRUCTURE; CELL VIABILITY; CLINICAL LABORATORY; CLINICAL PRACTICE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; FOOD AND DRUG ADMINISTRATION; GOOD LABORATORY PRACTICE; HUMAN; IMAGE ANALYSIS; INTERNATIONAL CLINICAL CYTOMETRY SOCIETY; INTERNATIONAL COOPERATION; INTERNATIONAL COUNCIL FOR STANDARDIZATION OF HEMATOLOGY; LABORATORY DEVELOPED TEST; LABORATORY TEST; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STANDARDIZATION; UNITED STATES;

FLOW CYTOMETRY; LABORATORY HEMATOLOGY; PRACTICE GUIDELINE; REGULATORY SCIENCE; STANDARDIZATION;

CLINICAL LABORATORY TECHNIQUES; FLOW CYTOMETRY; FLUORESCENT DYES; HEMATOLOGY; HUMANS; PRACTICE GUIDELINES AS TOPIC; REFERENCE STANDARDS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84884195144     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.21105     Document Type: Review

References (22)

1. Clinical and Laboratory Standards Institute (CLSI). Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline, 2nd ed. Wayne, PA: CLSI Document H43-A2, Vol. 27, No 11; 2007.
2. Clinical and Laboratory Standards Institute (CLSI). Enumeration of Immunologically Defined Cell Populations by Flow Cytometry; Approved Guideline, 2nd ed. Wayne, PA: CLSI Document H42-A2, Vol. 27, No. 16, 2007.
3. He W, Wang H, Hartmann LC, Cheng JX, Low PS,. In vivo quantitation of rare circulating tumor cells by multiphotonintravital flow cytometry. Proc Natl Acad Sci USA 2007; 104: 11760-11765.
4. Dharmasiri U, Witek MA, Adams AA, Soper SA,. Microsystems for the capture of low-abundance cells. Annu Rev Anal Chem 2010; 3: 409-431.
5. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless L, Cox C,. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993; 14: 472-477.
6. Duque RE, Andreeff M, Braylan RC, Diamond LW, Peiper SC,. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology. Cytometry 1993; 14: 492-496.
7. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW,. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon: IARC Press; 2008.
8. Davis BH, Holden JT, Bene MC, Borowitz MJ, Braylan RC, Cornfield D, Gorczyca W, Lee R, Maiese R, Orfao A, et al. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indications. Cytometry B Clin Cytom 2007; 72B (Suppl 1): S5-S13.
9. Clinical and Laboratory Standards Institute (CLSI), Wayne, PA. H3-A6: Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture; Approved Standard, 6th ed. Vol. 27, No. 26.
10. Clinical and Laboratory Standards Institute (CLSI), Wayne, PA. GP34-A: Validation and Verification of Tubes for Venous and Capillary Blood Specimen Collection; Approved Guideline. Vol. 30, No. 25.
11. Clinical and Laboratory Standards Institute (CLSI), Wayne, PA. H01-A6: Tubes & Additives for Venous and Capillary Blood Specimen Collection; Approved Standard, 6th ed. Vol. 30, No. 26.
12. Clinical and Laboratory Standards Institute (CLSI), Wayne, PA. M29-A3: Protection of Laboratory Workers from Occupationally Acquired Infections; Approved Guideline, 3rd ed. Vol. 25, No. 10.
13. Nicholson JK, Browning SW, Orloff SL, McDougal JS,. Inactivation of HIV-infected H9 cells in whole blood preparations by lysing/fixing reagents used in flow cytometry. J Immunol Methods 1993; 160: 215-218.
14. Centers for Disease Control, Atlanta, GA. Recommendations for prevention of HIV transmission in healthcare setting. MMWR 1987; 36: #2S.
15. Cory JM, Rapp F, Ohlsson-Wilhem BM,. Effects of cellular fixatives on human immunodeficiency virus production. Cytometry 1990; 11: 647-651.
16. Vos JA, Simurdak JH, Davis BJ, Myers JB, Brissette MD,. Vortex disaggregation for flow cytometry allows direct histologic correlation: A novel approach for small biopsies and in aspirable bone marrows. Cytometry B 2003; 52B: 20-31.
17. de Graaf MT, de Jongste AH, Kraan J, Boonstra JG, Sillevis Smitt PA, Gratama JW,. Flow cytometric characterization of cerebrospinal fluid cells. Cytometry B 2011; 80B: 271-281
18. Nicholson JK, Jones BM, Cross GD, McDougal JS,. Comparison of T and B cell analysis on fresh and aged blood. J Immunol Methods 1984; 73: 29-40.
19. Elghetany MT, Davis BH,. Impact of preanalytical variables on granulocytic surface antigen expression: A review. Cytometry B 2005; 65B: 1-5.
20. Interstate shipment of etiologic agents. 69 Federal Register 438-446. (Codified at 42 CFR 72); 2004.
21. Committee of Experts on the Transport of Dangerous Goods and on the Globally Harmonized System of Classification and Labeling of Chemicals; Subcommittee of Experts on the Transport of Dangerous Goods. 25th session; Geneva: 5-14 July 2004.
22. Gordon KM, Duckett L, Daul B, Petrie HT,. A simple method for detecting up to five immunofluorescent parameters together with DNA staining for cell cycle or viability on a bench top flow cytometer. J Immunol Methods 2003; 275: 113-121.